137310 — SD Biosensor Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
KR₩1tn
Enterprise Value
KR₩1tn
Revenue
KR₩695bn

Annual balance sheet for SD Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Interim Report	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	415,209	1,779,821	2,069,971	557,717	384,250
Net Total Accounts Receivable
Net Total Receivables	441,240	391,486	118,002	153,160	171,419
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,289,261	2,606,788	2,517,266	964,970	938,393
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	115,250	207,128	468,635	551,500	485,610
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,461,651	3,033,933	3,261,922	3,788,831	3,888,464
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	689,402	779,869	296,980	320,758	176,564
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	713,630	814,582	317,621	965,171	965,130
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	748,021	2,219,351	2,944,301	2,823,660	2,923,334
Total Liabilities & Shareholders' Equity	1,461,651	3,033,933	3,261,922	3,788,831	3,888,464
Total Common Shares Outstanding